Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Por um escritor misterioso
Descrição
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review - Zhu - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
Sonosensitive capsules for brain thrombolysis increase ischemic damage in a stroke model, Journal of Nanobiotechnology
Independent Study Demonstrates Stroke Patients Experience Superior Outcomes with Intra-Arterial Treatment vs. Tissue Plasminogen Activator (tPA)
Factors Driving Expanded Use of Tissue Plasminogen Activator for Acute Ischemic Stroke - ACEP Now
Hyperacute Management of Ischemic Strokes: JACC Focus Seminar
Acute Ischemic Stroke and Long-Term Outcome After Thrombolysis
Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke
:max_bytes(150000):strip_icc()/GettyImages-184312650-58f63f583df78ca159f37a44.jpg)
tPA (Tissue Plasminogen Activator) for Stroke
PDF) Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group
de
por adulto (o preço varia de acordo com o tamanho do grupo)
